Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frisch Medical Devices manufactures a range of cardiac intervention products including drug-eluting stents with sirolimus and everolimus, PTCA balloons, DCB/DEB with sirolimus drug, and various cardiac accessories. The company is ISO 13485 certified and holds GMP certification. Their products are designed for patient wellness and interventional cardiologist comfort; no clinical trial data is published as these are regulated medical devices rather than drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frisch Medical Devices.